Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Coates

Showing results (431-440 of 575) with videos related to

Pageof 58
Sort By:
Rheumatology (Oxford, England)|July 27, 2013
The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologicsLaura C Coates, William Tillett, David Chandler, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|July 26, 2022
The Battle of the Titans-Comparing Resuscitation Between Five Major Burn Centers Using the Burn NavigatorJulie A Rizzo, Nehemiah T Liu, Elsa C Coates, et al.
Rheumatology (Oxford, England)|October 19, 2017
Remission in psoriatic arthritis-where are we now?Laura C Coates, Philip G Conaghan, Maria Antonietta D'Agostino, et al.
The Journal of Rheumatology|March 2, 2022
Young-GRAPPA at the Annual GRAPPA Meeting: Presentation of a New Group Within GRAPPA and Its VisionLeonieke J J van Mens, Gizem Ayan, Laura C Coates, et al.
Health and Quality of Life Outcomes|June 10, 2020
Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaireL C Coates, A-M Orbai, V F Azevedo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 13, 2022
Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension StudyLaura C Coates, Iain B McInnes, Joseph F Merola, et al.
Arthritis Research & Therapy|December 12, 2018
Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 studyL C Coates, D D Gladman, P Nash, et al.
Trials|March 5, 2021
Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis-study protocol for the MONITOR-PsA study, a trials within cohorts study designInes Rombach, William Tillett, Deepak Jadon, et al.
Clinical Pharmacology and Therapeutics|October 23, 2025
Cohort Study on Drug Survival and Tolerability of Adalimumab Biosimilar Transitioning: Pharmaceutical Properties Do MatterAmy C D Peeters, Maike H M Wientjes, Wieland D Müskens, et al.
The Journal of Rheumatology|February 3, 2020
Appraisal of Candidate Instruments for Assessment of the Physical Function Domain in Patients with Psoriatic ArthritisYing Ying Leung, Ana-Maria Orbai, Alexis Ogdie, et al.
Pageof 58

Showing results (431-440 of 575) with videos related to

Sort By:
Pageof 58
Rheumatology (Oxford, England)|July 27, 2013
The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologicsLaura C Coates, William Tillett, David Chandler, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|July 26, 2022
The Battle of the Titans-Comparing Resuscitation Between Five Major Burn Centers Using the Burn NavigatorJulie A Rizzo, Nehemiah T Liu, Elsa C Coates, et al.
Rheumatology (Oxford, England)|October 19, 2017
Remission in psoriatic arthritis-where are we now?Laura C Coates, Philip G Conaghan, Maria Antonietta D'Agostino, et al.
The Journal of Rheumatology|March 2, 2022
Young-GRAPPA at the Annual GRAPPA Meeting: Presentation of a New Group Within GRAPPA and Its VisionLeonieke J J van Mens, Gizem Ayan, Laura C Coates, et al.
Health and Quality of Life Outcomes|June 10, 2020
Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaireL C Coates, A-M Orbai, V F Azevedo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 13, 2022
Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension StudyLaura C Coates, Iain B McInnes, Joseph F Merola, et al.
Arthritis Research & Therapy|December 12, 2018
Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 studyL C Coates, D D Gladman, P Nash, et al.
Trials|March 5, 2021
Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis-study protocol for the MONITOR-PsA study, a trials within cohorts study designInes Rombach, William Tillett, Deepak Jadon, et al.
Clinical Pharmacology and Therapeutics|October 23, 2025
Cohort Study on Drug Survival and Tolerability of Adalimumab Biosimilar Transitioning: Pharmaceutical Properties Do MatterAmy C D Peeters, Maike H M Wientjes, Wieland D Müskens, et al.
The Journal of Rheumatology|February 3, 2020
Appraisal of Candidate Instruments for Assessment of the Physical Function Domain in Patients with Psoriatic ArthritisYing Ying Leung, Ana-Maria Orbai, Alexis Ogdie, et al.
Pageof 58